Estates and Trusts - Interpretation of Wills - Evidence of Intent (Granny's Law)
HB868, titled “Granny’s Law,” changes Maryland probate law to give a personal representative a new way to ask the orphans’ court to interpret a will using extrinsic evidence of the decedent’s intent. The bill is aimed at wills that leave a legacy to a health provider or health-sector charity, but do not expressly say whether the gift must be used to address health equity issues. In those cases, if the personal representative can present satisfactory evidence—such as the decedent’s lifetime actions—the court must apply a rebuttable presumption that the legacy was intended to support health equity, unless that presumption is rebutted.
The bill also authorizes the court to defer to the personal representative’s judgment when the will contains broad administrative language giving the representative authority to manage estate property and business affairs without court direction. Under that framework, the representative’s actions to address health disparities are treated as authorized unless there is compelling evidence of conduct contrary to the decedent’s intent and intended to commit fraud against the estate. The bill further allows the representative, for a limited period after probate, to require a legatee to show how the legacy was used and to seek return of the gift or a money judgment if the use does not match the court’s interpretation of the will.
HB868 also adds a new policy statement to the Health-General Article declaring that Maryland opposes and seeks to alleviate racial disparities in health outcomes and encourages gifts and bequests consistent with that policy. The bill applies retroactively to wills probated on or after October 1, 2021, and takes effect October 1, 2025. In practical terms, it would affect estate administration, probate litigation, charitable beneficiaries, health-related nonprofits, and personal representatives handling wills with ambiguous charitable bequests.
The overall sentiment reflected in the bill text is strongly supportive of using estate gifts to advance health equity and of empowering personal representatives to enforce that purpose. Because there are no committee transcripts or recorded votes provided, there is no documented public debate in the supplied materials. Based on the structure of the bill, likely points of contention would include retroactive application, the breadth of discretion given to personal representatives, and the potential for beneficiaries to be required to account for or return inherited funds years after probate.
The main legal effect is to amend Estates and Trusts § 7-402 and add Health-General § 1-102, creating a new interpretive rule for certain wills and a state policy favoring health-disparity reduction through charitable giving. It would expand the role of extrinsic evidence in probate proceedings, create a rebuttable presumption about donor intent, and give courts authority to order repayment or return of legacies in specified circumstances.
HB868 would alter Maryland probate and estate-administration law by expanding when a court may look beyond the text of a will to determine a decedent’s intent, and by creating a specific presumption and enforcement mechanism for charitable gifts tied to health equity. It amends Estates and Trusts § 7-402 to authorize petitions by personal representatives in certain cases, and adds Health-General § 1-102 to state a policy favoring gifts and bequests that address racial health disparities. The bill would directly affect personal representatives, legatees, health providers, health-sector charities, and beneficiaries of wills probated on or after October 1, 2021, if the will falls within the bill’s scope.
The bill’s text reflects a clear pro-health-equity and pro-enforcement posture, suggesting support for using probate law to carry out a decedent’s charitable intentions in the health-disparities context. No committee testimony or vote record was provided, so there is no documented opposition or support from legislators or stakeholders in the supplied materials. On its face, the measure appears designed to strengthen the authority of personal representatives and courts to ensure that certain charitable bequests are used consistently with the decedent’s presumed intent.
Likely areas of contention include the bill’s retroactive application to wills probated on or after October 1, 2021, the use of extrinsic evidence to infer intent, and the broad authority given to personal representatives to challenge or police beneficiaries’ use of inherited funds. Beneficiaries and charitable organizations may object to the possibility of post-probate review, repayment demands, or court-ordered return of legacies. Supporters are likely to emphasize accountability, honoring donor intent, and advancing racial health equity through charitable bequests.